Taylor Hoffman Wealth Management’s GSK GSK Stock Holding History

Taylor Hoffman Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,200	Closed	-$61K	–	211
2020 Q2	$61K	Buy	+1,200	New	+$61.6K	0.04%	184
2020 Q1	–	Sell	-1,200	Closed	-$70K	–	215
2019 Q4	$70K	Hold	1,200	–	–	0.05%	188
2019 Q3	$64K	Buy	1,200 +960	+400%	+$49.4K	0.05%	185
2019 Q2	$12K	Sell	240 -960	-80%	-$48.2K	0.01%	274
2019 Q1	$63K	Hold	1,200	–	–	0.05%	177
2018 Q4	$57K	Hold	1,200	–	–	0.05%	165
2018 Q3	$60K	Hold	1,200	–	–	0.05%	170
2018 Q2	$60K	Hold	1,200	–	–	0.05%	161
2018 Q1	$59K	Hold	1,200	–	–	0.05%	171
2017 Q4	$53K	Buy	+1,200	New	+$55.4K	0.05%	186

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Taylor Hoffman Wealth Management's GSK Position: Q3 2020 in Review

Taylor Hoffman Wealth Management sold out of GSK (GSK) in Q3 2020, closing a stake of 1,200 shares — an estimated $61K sold.

Taylor Hoffman Wealth Management first reported a position in GSK in Q4 2017 and held it in 10 quarters. The position peaked at $70K in Q4 2019. 826 funds tracked by Wall St. Rank hold GSK as of Q3 2020.

Taylor Hoffman Wealth Management reported no remaining GSK position as of Q3 2020 after selling out during the quarter.
Taylor Hoffman Wealth Management sold 1,200 GSK shares in Q3 2020, an estimated $61K.
Taylor Hoffman Wealth Management first reported a position in GSK in Q4 2017 and held it in 10 quarters.
Taylor Hoffman Wealth Management's GSK position peaked at $70K in Q4 2019.
826 funds tracked by Wall St. Rank held GSK as of Q3 2020.

Based on Taylor Hoffman Wealth Management's 13F filing for Q3 2020, filed 29 Oct 2020.